Fulcrum Therapeutics (FULC) Receivables - Other (2020 - 2025)
Historic Receivables - Other for Fulcrum Therapeutics (FULC) over the last 6 years, with Q1 2025 value amounting to $979000.0.
- Fulcrum Therapeutics' Receivables - Other changed N/A to $979000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $979000.0, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is 29031.66% up from last year.
- According to the latest figures from Q1 2025, Fulcrum Therapeutics' Receivables - Other is $979000.0.
- Fulcrum Therapeutics' 5-year Receivables - Other high stood at $3.7 million for Q3 2024, and its period low was $99000.0 during Q1 2023.
- Its 5-year average for Receivables - Other is $1.1 million, with a median of $766500.0 in 2022.
- Per our database at Business Quant, Fulcrum Therapeutics' Receivables - Other crashed by 8765.59% in 2023 and then skyrocketed by 53034.48% in 2024.
- Over the past 5 years, Fulcrum Therapeutics' Receivables - Other (Quarter) stood at $1.1 million in 2021, then crashed by 79.86% to $229000.0 in 2022, then skyrocketed by 134.5% to $537000.0 in 2023, then surged by 290.32% to $2.1 million in 2024, then crashed by 53.29% to $979000.0 in 2025.
- Its Receivables - Other stands at $979000.0 for Q1 2025, versus $2.1 million for Q4 2024 and $3.7 million for Q3 2024.